Revolution Medicines, Inc.(NASDAQ : RVMD)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Other
|SAVA||Cassava Sciences, Inc.||-0.45%||78.25||0.0%||$189.96m|
|VRX||Valeant Pharmaceuticals International, Inc.||-1.98%||29.20||14.1%||$171.82m|
|HZNP||Horizon Therapeutics Plc||-1.01%||91.21||5.5%||$142.01m|
|JAZZ||Jazz Pharmaceuticals Plc||-1.19%||175.64||2.2%||$114.63m|
|SAGE||SAGE Therapeutics, Inc.||1.49%||55.99||7.6%||$65.80m|
|UTHR||United Therapeutics Corp.||-1.77%||179.18||14.0%||$65.23m|
|BHC||Bausch Health Cos., Inc.||-2.01%||29.19||0.0%||$59.99m|
|PRGO||Perrigo Co. Plc||-0.78%||47.33||6.9%||$54.44m|
|PCRX||Pacira Biosciences, Inc.||-2.18%||59.14||9.9%||$27.07m|
|AXSM||Axsome Therapeutics, Inc.||-0.66%||66.10||1.9%||$22.03m|
|RVMD||Revolution Medicines, Inc.||-2.76%||33.10||0.0%||$21.97m|
|IRWD||Ironwood Pharmaceuticals, Inc.||0.83%||11.57||9.6%||$20.76m|
Revolution Medicines, Inc. is a clinical-stage precision oncology company focused on developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.